Sean H Lim

11PUBLICATIONS
73CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 15, 2026
Anti-TNFR2 antibody BI-1808 induces tumor regression and antitumor T cell immunity through T reg and myeloid cell modulation in patients with solid tumors.

|Jul 17, 2026
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity.

|Dec 20, 2025
Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Marcus A Widdess, Anastasia Pakidi, Hannah J Metcalfe

|Sep 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

Kirstie L S Cleary, Monika Semmrich, Linda Martensson

|Sep 08, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Lara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli

|Dec 28, 2023
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

Sean H Lim, Stephen A Beers, Aymen Al-Shamkhani

Pageof 2

Frequent Collaborators

8 joint publications

Mark S Cragg

6 joint publications

Stephen A Beers

3 joint publications

Linda Martensson

3 joint publications

Petra Holmkvist